These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3466790)

  • 1. Induction of anti-HIV neutralizing antibodies by synthetic peptides.
    Chanh TC; Dreesman GR; Kanda P; Linette GP; Sparrow JT; Ho DD; Kennedy RC
    EMBO J; 1986 Nov; 5(11):3065-71. PubMed ID: 3466790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.
    Goudsmit J; Debouck C; Meloen RH; Smit L; Bakker M; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4478-82. PubMed ID: 2454471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ; Matthews TJ; Langlois A; Tanner ME; Martin ME; Scearce RM; Kim JE; Berzofsky JA; Bolognesi DP; Haynes BF
    J Immunol; 1989 May; 142(10):3612-9. PubMed ID: 2469721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
    Palker TJ; Clark ME; Langlois AJ; Matthews TJ; Weinhold KJ; Randall RR; Bolognesi DP; Haynes BF
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1932-6. PubMed ID: 2450351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.
    Matthews TJ; Langlois AJ; Robey WG; Chang NT; Gallo RC; Fischinger PJ; Bolognesi DP
    Haematol Blood Transfus; 1987; 31():414-22. PubMed ID: 2832276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
    Palker TJ; Riggs ER; Spragion DE; Muir AJ; Scearce RM; Randall RR; McAdams MW; McKnight A; Clapham PR; Weiss RA
    J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.
    Palker TJ; Matthews TJ; Clark ME; Cianciolo GJ; Randall RR; Langlois AJ; White GC; Safai B; Snyderman R; Bolognesi DP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2479-83. PubMed ID: 2436231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
    Robey WG; Arthur LO; Matthews TJ; Langlois A; Copeland TD; Lerche NW; Oroszlan S; Bolognesi DP; Gilden RV; Fischinger PJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7023-7. PubMed ID: 3018753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
    Matsushita S; Robert-Guroff M; Rusche J; Koito A; Hattori T; Hoshino H; Javaherian K; Takatsuki K; Putney S
    J Virol; 1988 Jun; 62(6):2107-14. PubMed ID: 2452899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).
    Harada S; Kobayashi N; Koyanagi Y; Yamamoto N
    Virology; 1987 Jun; 158(2):447-51. PubMed ID: 2438845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
    Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR
    Science; 1986 Mar; 231(4745):1556-9. PubMed ID: 3006246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
    Putney SD; Matthews TJ; Robey WG; Lynn DL; Robert-Guroff M; Mueller WT; Langlois AJ; Ghrayeb J; Petteway SR; Weinhold KJ
    Science; 1986 Dec; 234(4782):1392-5. PubMed ID: 2431482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).
    Neurath AR; Strick N
    Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
    Ho DD; Sarngadharan MG; Hirsch MS; Schooley RT; Rota TR; Kennedy RC; Chanh TC; Sato VL
    J Virol; 1987 Jun; 61(6):2024-8. PubMed ID: 2437327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
    J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable and conserved neutralization antigens of human immunodeficiency virus.
    Weiss RA; Clapham PR; Weber JN; Dalgleish AG; Lasky LA; Berman PW
    Nature; 1986 Dec 11-17; 324(6097):572-5. PubMed ID: 2431324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
    Broliden PA; von Gegerfelt A; Clapham P; Rosen J; Fenyö EM; Wahren B; Broliden K
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):461-5. PubMed ID: 1370580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.
    Hart MK; Palker TJ; Matthews TJ; Langlois AJ; Lerche NW; Martin ME; Scearce RM; McDanal C; Bolognesi DP; Haynes BF
    J Immunol; 1990 Oct; 145(8):2677-85. PubMed ID: 1698859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.